Scarica l'app Stockscreener
5.39
4.77%
-0.27
Dopo l'orario di chiusura:
5.39
Precedente Chiudi:
$5.66
Aprire:
$5.72
Volume 24 ore:
600.78K
Relative Volume:
0.70
Capitalizzazione di mercato:
$322.84M
Reddito:
-
Utile/perdita netta:
$-44.80M
Rapporto P/E:
-7.1867
EPS:
-0.75
Flusso di cassa netto:
$-30.67M
1 W Prestazione:
-4.94%
1M Prestazione:
+8.67%
6M Prestazione:
+168.16%
1 anno Prestazione:
-3.06%
Intervallo 1D:
$5.39
$5.79
Intervallo di 1 settimana:
$5.12
$5.79
Portata 52W:
$1.14
$7.20
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
Nome
Aldeyra Therapeutics Inc
Settore
Industria
Telefono
781-761-4904
Indirizzo
131 HARTWELL AVENUE, LEXINGTON, MA
Confronta ALDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
5.39 | 320.64M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-03 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Ripresa | H.C. Wainwright | Buy |
| 2022-04-27 | Ripresa | H.C. Wainwright | Buy |
| 2021-02-08 | Iniziato | H.C. Wainwright | Buy |
| 2020-12-16 | Iniziato | Berenberg | Buy |
| 2020-10-30 | Iniziato | Jefferies | Buy |
| 2020-10-16 | Iniziato | BTIG Research | Buy |
| 2020-09-22 | Iniziato | Alliance Global Partners | Buy |
| 2020-05-12 | Iniziato | Oppenheimer | Outperform |
| 2018-12-04 | Iniziato | Citigroup | Buy |
| 2018-09-26 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Iniziato | Janney | Buy |
| 2018-01-26 | Iniziato | Seaport Global Securities | Buy |
| 2016-09-26 | Iniziato | H.C. Wainwright | Buy |
| 2016-07-01 | Iniziato | Stifel | Buy |
| 2015-07-01 | Iniziato | Canaccord Genuity | Buy |
| 2015-03-25 | Iniziato | Chardan Capital Markets | Buy |
| 2015-03-20 | Reiterato | H.C. Wainwright | Buy |
| 2014-11-18 | Iniziato | H.C. Wainwright | Buy |
| 2014-06-19 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie
Is Aldeyra Therapeutics Inc. stock attractive for ETFsWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Why analysts upgrade Aldeyra Therapeutics Inc. stockTrade Signal Summary & Consistent Return Strategy Ideas - newser.com
Developing predictive dashboards with Aldeyra Therapeutics Inc. data2025 Pullback Review & Free Verified High Yield Trade Plans - newser.com
Evaluating Aldeyra Therapeutics Inc. with trendline analysisQuarterly Growth Report & Detailed Earnings Play Alerts - newser.com
Will Aldeyra Therapeutics Inc. stock split again soonQuarterly Performance Summary & Consistent Return Investment Signals - newser.com
Risk adjusted return profile for Aldeyra Therapeutics Inc. analyzedTake Profit & Weekly High Potential Alerts - newser.com
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat
Relative strength of Aldeyra Therapeutics Inc. in sector analysis - newser.com
When is the best time to exit Aldeyra Therapeutics Inc.Quarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
Statistical indicators supporting Aldeyra Therapeutics Inc.’s strengthInsider Selling & Fast Gain Swing Alerts - newser.com
How to forecast Aldeyra Therapeutics Inc. trends using time seriesTrend Reversal & Consistent Growth Stock Picks - newser.com
Is Aldeyra Therapeutics Inc. stock reversal real or fakeWeekly Trade Report & Safe Capital Growth Trade Ideas - newser.com
4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals - Benzinga
Analyzing recovery setups for Aldeyra Therapeutics Inc. investorsJuly 2025 Volume & Verified High Yield Trade Plans - newser.com
Jefferies raises Aldeyra Therapeutics stock price target to $7 on FDA acceptance - Investing.com Canada
Aldeyra Therapeutics' (ALDX) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
4 Biotech Stocks Seeing Explosive Momentum GainsAldeyra Therapeutics (NASDAQ:ALDX) - Benzinga
Will Aldeyra Therapeutics Inc. see short term momentum2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com
How to track smart money flows in Aldeyra Therapeutics Inc.Quarterly Profit Review & Short-Term High Return Strategies - newser.com
Is this a good reentry point in Aldeyra Therapeutics Inc.July 2025 Analyst Calls & Low Risk Investment Opportunities - newser.com
Using Ichimoku Cloud for Aldeyra Therapeutics Inc. technicalsMarket Weekly Review & Precise Swing Trade Alerts - newser.com
Can Aldeyra Therapeutics Inc. rally from current levels2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
PFG Investments LLC Has $985,000 Holdings in Aldeyra Therapeutics, Inc. $ALDX - MarketBeat
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Passes Below Fifty Day Moving AverageWhat's Next? - MarketBeat
Multi factor analysis applied to Aldeyra Therapeutics Inc.Quarterly Growth Report & AI Forecast Swing Trade Picks - newser.com
ALDX stock touches 52-week high at $6.6 amid robust annual gains - MSN
High Growth Tech Stocks In The US For September 2025 - simplywall.st
High Growth Tech Stocks In The US Market With Promising Potential - Yahoo Finance
Aldeyra Therapeutics Inc Azioni (ALDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aldeyra Therapeutics Inc Azioni (ALDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Machatha Stephen | Chief Development Officer |
Aug 11 '25 |
Sale |
5.15 |
22,073 |
113,713 |
221,799 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):